Compare · ESTA vs ZBH
ESTA vs ZBH
Side-by-side comparison of Establishment Labs Holdings Inc. (ESTA) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ESTA and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $17.67B, about 9.1x ESTA ($1.95B).
- Over the past year, ESTA is up 123.8% and ZBH is down 10.2% - ESTA leads by 134.0 points.
- ESTA has been more active in the news (7 items in the past 4 weeks vs 2 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 13 for ESTA).
- Company
- Establishment Labs Holdings Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $66.24+1.69%
- $91.33-1.18%
- Market cap
- $1.95B
- $17.67B
- 1M return
- +11.16%
- +4.25%
- 1Y return
- +123.82%
- -10.23%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- News (4w)
- 7
- 2
- Recent ratings
- 13
- 25
Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest ESTA
- SEC Form DEFA14A filed by Establishment Labs Holdings Inc.
- Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
- SEC Form 4 filed by Chacon Quiros Juan Jose
- SEC Form DEFA14A filed by Establishment Labs Holdings Inc.
- SEC Form DEF 14A filed by Establishment Labs Holdings Inc.
- Amendment: SEC Form 4 filed by Caldini Filippo
- Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market
- SEC Form 4 filed by Schutter Edward J
- SEC Form 4 filed by Gillin Leslie
- SEC Form 4 filed by Slotkin Bryan
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert